JUUL Labs, one of the companies behind the production of electronic cigarettes, has landed itself in the headlines again. A recent study from Stanford University’s School of Medicine revealed that teens and young adults who use e-cigarettes are at “a substantially increased risk of COVID-19.” Specifically, the study divulged that young people who used both cigarettes and e-cigarettes in the previous month were five times as likely to experience COVID-19 symptoms as someone who never smoked or vaped.
To read more about E-Cigarettes and Vaping, click here.
The Need for Regulation of Electronic Cigarettes
In response to these results, JUUL Labs filed Premarket Tobacco Product Applications for its e-cigarettes and nicotine cartridges, which will undergo a “substantive scientific review” by the Food and Drug Administration (FDA).
“Now is the time,” stressed Dr. Bonnie Halpern-Felsher, the study’s author. “We need the FDA to hurry up and regulate these products. And we need to tell everyone: If you are a vaper, you are putting yourself at risk for COVID-19 and other lung diseases.”
Currently facing over 650 lawsuits as well as a criminal investigation that was launched in September 2019, JUUL Labs is committed to working collaboratively with regulators, legislators, attorneys general, and public health officials to “combat underage use and transition adult smokers from combustible cigarettes.” As part of the process, the company has halted all television, print, and digital advertising as it builds up the science and evidence-based research behind its products.